<?xml version="1.0" encoding="UTF-8" ?>
	<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	  <channel>
	  <copyright>Copyright 2009 Medical News Today</copyright>
	  <description>Latest Bones / Orthopaedics News From Medical News Today.</description>
	  <link>http://www.medicalnewstoday.com/sections/bones/</link>
	  <title>Bones / Orthopaedics News From Medical News Today</title>
	  <webMaster>admin&#064;medicalnewstoday.com  (MNT Admin)</webMaster>
	  <managingEditor>editors&#064;medicalnewstoday.com  (MNT Editors)</managingEditor>
	  <language>en-us</language><atom:link href="http://www.medicalnewstoday.com/rss/bones-bone_disorders.xml" rel="self" type="application/rss+xml" /><item><title>What Is Cartilage Damage? What Is Articular Cartilage Damage?</title><pubDate>Sat, 21 Nov 2009 04:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/171780.php</link><guid>http://www.medicalnewstoday.com/articles/171780.php</guid><description>Cartilage structures and functions can relatively easily be harmed, often resulting in damage.  Cartilage is a tough, flexible connective tissue that is found in many areas of the body. This fine, rubbery tissue mainly functions as a cushion for bones at joints. The English word "cartilage" comes from the Latin word cartilage, which means "cartilage" or "gristle".</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>What Is Bone Cancer (Sarcoma)? What Causes Bone Cancer?</title><pubDate>Thu, 19 Nov 2009 00:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/171372.php</link><guid>http://www.medicalnewstoday.com/articles/171372.php</guid><description>Bone cancer is an uncommon cancer that begins in a bone. It can originate in any bone in the body, but the long bones that make up the arms and legs are most commonly affected.   Several types of bone cancer exist. Some types of bone cancer occur primarily in children, while others affect mostly adults.   Primary bone cancer is cancer that starts in the bone.</description><category domain="http://www.medicalnewstoday.com/sections/cancer-oncology/">Cancer / Oncology</category></item><item><title> 25&#45;Year Review Shows Last&#45;Resort Lower&#45;Body Amputation Effective In Extreme Cases</title><pubDate>Wed, 18 Nov 2009 06:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/171369.php</link><guid>http://www.medicalnewstoday.com/articles/171369.php</guid><description> A landmark, 25&#45;year review of cases in which surgeons had to remove the lower portion of the body from the waist down for severe pelvic bone infections shows the therapy can add years and quality of life to survivors, say researchers at UT Southwestern Medical Center.    The rarely performed surgery is called a hemicorporectomy or translumbar amputation, and involves removing the entire body below the waist, including legs, pelvic bone and urinary system.</description><category domain="http://www.medicalnewstoday.com/sections/infectious_diseases/">Infectious Diseases / Bacteria / Viruses</category></item><item><title>Last&#45;Resort Lower&#45;Body Amputation Effective In Extreme Cases Of Bone Infection</title><pubDate>Wed, 18 Nov 2009 01:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/171250.php</link><guid>http://www.medicalnewstoday.com/articles/171250.php</guid><description>A landmark, 25&#45;year review of cases in which surgeons had to remove the lower portion of the body from the waist down for severe pelvic bone infections shows the therapy can add years and quality of life to survivors, say researchers at UT Southwestern Medical Center.   The rarely performed surgery is called a hemicorporectomy or translumbar amputation, and involves removing the entire body below the waist, including legs, pelvic bone and urinary system.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>American Academy Of Orthopaedic Surgeons Wins Prestigious CLIO Award</title><pubDate>Tue, 17 Nov 2009 16:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/171195.php</link><guid>http://www.medicalnewstoday.com/articles/171195.php</guid><description>The first&#45;ever CLIO Healthcare Award &#45; a new category of the internationally distinguished CLIO Awards &#45;&#45; has awarded the American Academy of Orthopaedic Surgeons (AAOS), a Silver CLIO for the Academy's year&#45;long campaign "75 Years of Orthopaedic History.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>Mutation In A MiroRNA: New Cause Of Osteoporosis</title><pubDate>Tue, 17 Nov 2009 04:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/171168.php</link><guid>http://www.medicalnewstoday.com/articles/171168.php</guid><description>Many biological processes are controlled by small molecules known as microRNAs, which work by suppressing the expression of specific sets of genes. Xiang&#45;Hang Luo and colleagues, at Second Xiangya Hospital of Central South University, People's Republic of China, have now identified a previously unknown microRNA (miR&#45;2861) as crucial to bone maintenance in mice and humans.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>Heart And Bone Damage From Low Vitamin D Tied To Declines In Sex Hormones</title><pubDate>Mon, 16 Nov 2009 02:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/171038.php</link><guid>http://www.medicalnewstoday.com/articles/171038.php</guid><description> Researchers at Johns Hopkins are reporting what is believed to be the first conclusive evidence in men that the long&#45;term ill effects of vitamin D deficiency are amplified by lower levels of the key sex hormone estrogen, but not testosterone.  In a national study in 1010 men, to be presented Nov.</description><category domain="http://www.medicalnewstoday.com/sections/complementary_medicine/">Complementary Medicine / Alternative Medicine</category></item><item><title>Vitamin D Deficiency Linked To Cardiovascular Disease And Death By New Study</title><pubDate>Mon, 16 Nov 2009 01:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/171029.php</link><guid>http://www.medicalnewstoday.com/articles/171029.php</guid><description>While mothers have known that feeding their kids milk builds strong bones, a new study by researchers at the Heart Institute at Intermountain Medical Center in Salt Lake City suggests that Vitamin D contributes to a strong and healthy heart as well &#45; and that inadequate levels of the vitamin may significantly increase a person's risk of stroke, heart disease, and death, even among people who've never had heart disease.</description><category domain="http://www.medicalnewstoday.com/sections/heart-disease/">Heart Disease</category></item><item><title>What Is Short Stature (Dwarfism)? What Causes Short Stature?</title><pubDate>Fri, 13 Nov 2009 03:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/170880.php</link><guid>http://www.medicalnewstoday.com/articles/170880.php</guid><description>Dwarfism, nanism, short stature, or restricted growth is a medical disorder in which the person is of abnormally short stature. According to various sources, short stature may be caused by over 200 different medical conditions. According to the LPA (Little People of America), dwarfism is defined as an adult height of 4 feet 10 inches (148 cm) or less. However, as population groups around the world have varying average statures, height definition may vary.</description><category domain="http://www.medicalnewstoday.com/sections/pediatrics/">Pediatrics / Children's Health</category></item><item><title>Study Provides First Clear Idea Of How Rare Bone Disease Progresses</title><pubDate>Fri, 13 Nov 2009 01:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/170808.php</link><guid>http://www.medicalnewstoday.com/articles/170808.php</guid><description>An international team of scientists, led by researchers at the University of Pennsylvania School of Medicine, is taking the first step in developing a treatment for a rare genetic disorder called fibrodysplasia ossificans progressiva (FOP), in which the body's skeletal muscles and soft connective tissue turns to bone, immobilizing patients over a lifetime with a second skeleton.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>Zosano Pharma, Inc. Announces Publication Of Positive Phase 2 Study Of Its ZP&#45;PTH Patch For Osteoporosis Therapy</title><pubDate>Wed, 11 Nov 2009 01:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/170487.php</link><guid>http://www.medicalnewstoday.com/articles/170487.php</guid><description>Zosano Pharma, Inc., a privately held pharmaceutical company developing products using a novel transdermal delivery technology, announced publication in the current issue of the Journal of Clinical Endocrinology and Metabolism of results from a positive phase 2 study of its rapid&#45;delivery transdermal patch (ZP&#45;PTH) for the treatment of postmenopausal osteoporosis. The study by authors Felicia Cosman, Nancy E. Lane, Michael A. Bolognese, Jose R. Zanchetta, Pedro A.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>Wright Medical Group, Inc. Receives FDA Approval To Market CONSERVE(R) Plus Total Hip Resurfacing System</title><pubDate>Wed, 11 Nov 2009 01:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/170488.php</link><guid>http://www.medicalnewstoday.com/articles/170488.php</guid><description>Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, announced that the United States Food and Drug Administration (FDA) has given approval to the Company to market its original CONSERVE&#174; Plus Total Hip Resurfacing System. Now available in the United States, this innovative total surface arthroplasty system provides surgeons and their patients a bone&#45;conserving alternative to traditional total hip replacement.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>Link Between Depression And Osteoporosis</title><pubDate>Tue, 10 Nov 2009 05:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/170433.php</link><guid>http://www.medicalnewstoday.com/articles/170433.php</guid><description>Research carried out among thousands of people has shown a clear connection between depression and a loss of bone mass, leading to osteoporosis and fractures.    This was revealed by Hebrew University of Jerusalem researchers, Prof. Raz Yirmiya, head of the Brain and Behavior Laboratory, and Prof. Itai Bab, head of the Bone Laboratory. They further revealed that the relationship between depression and bone loss is particularly strong among young women.</description><category domain="http://www.medicalnewstoday.com/sections/depression/">Depression</category></item><item><title>Cytokinetics Announces Advancement Of CK&#45;2017357 In Phase I Clinical Trials</title><pubDate>Tue, 10 Nov 2009 01:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/170333.php</link><guid>http://www.medicalnewstoday.com/articles/170333.php</guid><description> Cytokinetics, Incorporated (NASDAQ: CYTK) announced the initiation of a double&#45;blind, randomized, placebo&#45;controlled, multiple&#45;dose Phase I clinical trial to investigate the pharmacokinetic profile of CK&#45;2017357. Cytokinetics also announced that the company has initiated the second part, or "Part B", of a previously initiated first&#45;time&#45;in&#45;humans, Phase I clinical trial of CK&#45;2017357 in healthy male volunteers.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>Early Menopause No Predictor Of Hip Fracture</title><pubDate>Tue, 10 Nov 2009 00:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/170315.php</link><guid>http://www.medicalnewstoday.com/articles/170315.php</guid><description>Women who have an early menopause are unlikely to have a long term increased risk of hip fractures associated with menopausal bone density weakening, according to a new study from The Australian National University.      For decades medical practitioners have understood a link between menopause and a decrease in bone density.</description><category domain="http://www.medicalnewstoday.com/sections/menopause/">Menopause</category></item><item><title>$11 Million NIH Grant For Stem Cell Research Awarded To Rhode Island Hospital</title><pubDate>Sat, 07 Nov 2009 01:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/170162.php</link><guid>http://www.medicalnewstoday.com/articles/170162.php</guid><description>Rhode Island Hospital has received an $11 million grant to fund research that will lead to a general understanding of stem cell biology and identify unique approaches to tissue regeneration in lung and marrow diseases. The 5&#45;year grant, awarded to Peter Quesenberry, MD, director of hematology/oncology at Rhode Island Hospital, also provides funding for the development of a major stem cell research center at Rhode Island Hospital.</description><category domain="http://www.medicalnewstoday.com/sections/stem_cell/">Stem Cell Research</category></item><item><title>Approved Lymphoma Drug Shows Promise In Early Tests Against Bone Cancer</title><pubDate>Fri, 06 Nov 2009 02:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/170040.php</link><guid>http://www.medicalnewstoday.com/articles/170040.php</guid><description>A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens, according to an early&#45;stage study published online in the International Journal of Cancer. The study drug, Bortezomib, was found to be effective against bone cancer in human cancer cell studies and in mice.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>Custom Spine Receives 510k Clearance Of Regent ACP</title><pubDate>Fri, 06 Nov 2009 02:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/170045.php</link><guid>http://www.medicalnewstoday.com/articles/170045.php</guid><description>Regent ACP, Custom Spine's anterior cervical plate system, has received 510k Clearance from the U.S. Food and Drug Administration (FDA). This product clearance marks the latest addition to Custom Spine's continually expanding product line.    Regent ACP is a low profile anterior cervical plate system that was designed with innovative self&#45;locking slides to give the surgeon confidence of the plate being securely locked into place.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>American Association Of Orthopaedic Surgeons, Nineteen Other Surgical Groups Call For Changes To Senate Health Legislation</title><pubDate>Fri, 06 Nov 2009 01:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/170034.php</link><guid>http://www.medicalnewstoday.com/articles/170034.php</guid><description>The American Association of Orthopaedic Surgeons (AAOS) joined nineteen other surgical organizations, led by the American College of Surgeons, to send a letter to the U.S. Senate today reiterating they are prepared to oppose the Senate's health care reform bill due to its threat to patients' access to specialty care and its potential to harm quality care. This coalition represents over 240,000 surgeons and anesthesiologists.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>First&#45;Ever Leading Calcium Supplement To Help Support Bone and Heart Health</title><pubDate>Fri, 06 Nov 2009 00:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/170010.php</link><guid>http://www.medicalnewstoday.com/articles/170010.php</guid><description>Bone strength and heart health are two of the most important health issues for women. One out of every two women will have an osteoporosis&#45;related fracture in her lifetime and more than 50 million women have blood cholesterol levels high enough to pose a risk for heart disease. Now there is a new product available to help address both of these issues at the same time.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>New Lung Health Research Presented At CHEST 2009</title><pubDate>Thu, 05 Nov 2009 04:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/169946.php</link><guid>http://www.medicalnewstoday.com/articles/169946.php</guid><description>Osteoporosis Linked to Bronchiectasis  (#8660)    Patients with non&#45;cystic fibrosis bronchiectasis may have a high incidence of osteopenia and osteoporosis. Researchers from Scott &#38; White Hospital and Texas A&#38;M Health Science Center College of Medicine in Texas reviewed the records of 113 patients admitted to the hospital with acute exacerbation of bronchiectasis. The mean age of the patients was 63 years, 76 percent were Caucasian, and 70 percent were women.</description><category domain="http://www.medicalnewstoday.com/sections/asthma-respiratory/">Respiratory / Asthma</category></item><item><title>BioMimetic Therapeutics Receives First Orthopedic Marketing Approval For Augment&#x2122; Bone Graft</title><pubDate>Wed, 04 Nov 2009 16:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/169844.php</link><guid>http://www.medicalnewstoday.com/articles/169844.php</guid><description>BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that it has received approval from Health Canada to begin the marketing of its lead orthopedic product, Augment&#x2122; Bone Graft, as an alternative to the use of autograft in midfoot, hindfoot and ankle fusion indications in Canada.   "After rigorous pre&#45;clinical and clinical evaluation of the product, BioMimetic is now ready to introduce this novel, implantable biologic to the marketplace," commented Dr. Samuel E.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>Enobia Expands Clinical Program For ENB&#45;0040, A Bone&#45;Targeted Enzyme Replacement Therapy For Hypophosphatasia</title><pubDate>Wed, 04 Nov 2009 02:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/169745.php</link><guid>http://www.medicalnewstoday.com/articles/169745.php</guid><description>Enobia Pharma announced the initiation of a Phase 2 clinical study of ENB&#45;0040, a bone&#45;targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). The six&#45;month study will assess the safety, efficacy and pharmacokinetics of ENB&#45;0040 in up to 12 children with HPP.</description><category domain="http://www.medicalnewstoday.com/sections/endocrinology/">Endocrinology</category></item><item><title>Improved Healing Of Bone Fractures After Radiation Exposure</title><pubDate>Tue, 03 Nov 2009 06:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/169677.php</link><guid>http://www.medicalnewstoday.com/articles/169677.php</guid><description>A drug currently under development by the University of Pittsburgh School of Medicine may help bone fractures heal more quickly after radiation exposure, according to a study by Pitt researchers. The study's results were presented during the American Society for Radiation Oncology (ASTRO) annual meeting in Chicago.    The drug, JP4&#45;039, is a free&#45;radical scavenger targeted to the mitochondria, the energy generator of all cells.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item><item><title>Aggressive Osteoporosis Prevention Could See Nation's Hip Fracture Rate Drop 25 Percent</title><pubDate>Tue, 03 Nov 2009 03:00:00 PST</pubDate><link>http://www.medicalnewstoday.com/articles/169584.php</link><guid>http://www.medicalnewstoday.com/articles/169584.php</guid><description>Aggressively managing patients at risk for osteoporosis could reduce the hip fracture rate in the United States by 25 percent, according to a Kaiser Permanente study published in the November issue of the Journal of Bone &#38; Joint Surgery. The first step must be a more active role by orthopedic surgeons in osteoporosis disease management, researchers say.</description><category domain="http://www.medicalnewstoday.com/sections/bones/">Bones / Orthopaedics</category></item></channel></rss>